{"product_id":"global-rigid-endoscopes-market-size-study-forecast-by-product-laparoscopes-arthroscopes-ureteroscopes-cystoscopes-gynecology-endoscopes-neuroendoscopes-and-others-by-end-use-hospitals-and-outpatient-facilities-and-regional-analysis-2022-2029","title":"Global Rigid Endoscopes Market Size study \u0026 Forecast, by Product (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes and Others) by End Use (Hospitals and Outpatient Facilities), and Regional Analysis, 2022-2029","description":"\u003cp\u003eGlobal Rigid Endoscopes Market Size study \u0026amp; Forecast, by Product (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes and Others) by End Use (Hospitals and Outpatient Facilities), and Regional Analysis, 2022-2029\u003cbr\u003e\nGlobal Rigid Endoscopes Market is valued at approximately USD 5.60 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.10% over the forecast period 2022-2029. Rigid endoscopes have an extensive range of exterior diameters, from 1 to 12 mm, and are made of metal tubes that house the lenses and light channel. Usually, high-resolution optical glass rod lenses are found on rigid endoscopes. The Rigid Endoscopes Market is expanding because of factors such as rising demand for minimally invasive surgical procedure and the growing prevalence of chronic diseases across the world.\u003c\/p\u003e\n\n\u003cp\u003eSeveral people around the world struggle with chronic conditions such as endometriosis and liver cancer. According to WHO factsheets from 2021, endometriosis affects over 190 million women worldwide who are of reproductive age. Similar to this, one of the most typical tumours detected in the female reproductive system is uterine fibroids (UFs), also known as uterine leiomyoma (UL), fibroma, or leiomyoma. For instance, a recent study in 2022 indicates that the possibility of having UFs is projected to be between 20% and 77%; the likelihood of having this condition is estimated to be between 40% and 60% among women under the age of 35 and to be between 70% and 80% among women over the age of 50. The increased prevalence of these illnesses is anticipated to enhance laparoscopic treatments in the future and hence promote the demand for rigid endoscopes. In addition, increasing healthcare spending and rising prevalence of gastrointestinal and gynecological cases and rising FDA approvals is catering for the market growth. However, the high cost of rigid endoscopes may halt market growth.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Rigid Endoscopes Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, and the geographic expansion of key players.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nOlympus Corporation\u003cbr\u003e\nEthicon U.S., LLC\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nKarl Storz GmbH \u0026amp; Co. KG\u003cbr\u003e\nStryker\u003cbr\u003e\nPENTAX Medical\u003cbr\u003e\nRichard Wolf GmbH\u003cbr\u003e\nMedtronic\u003cbr\u003e\nFUJIFILM Holdings Corp.\u003cbr\u003e\nCONMED Corp.\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\n? In January 2021, Olympus Corp. announced the acquisition of Quest Photonic Devices. These acquisitions take place to strengthen the company’s presence in the surgical endoscopy market.\u003c\/p\u003e\n\n\n\n\n\u003cp\u003eGlobal Rigid Endoscopes Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Product, End Use, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Product:\u003cbr\u003e\nLaparoscopes\u003cbr\u003e\nArthroscopes\u003cbr\u003e\nUreteroscopes\u003cbr\u003e\nCystoscopes\u003cbr\u003e\nGynecology Endoscopes\u003cbr\u003e\nNeuroendoscopes\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy End Use:\u003cbr\u003e\nHospitals\u003cbr\u003e\nOutpatient Facilities\u003c\/p\u003e\n\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRoLA\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003cbr\u003e\nOlympus Corporation\u003cbr\u003e\nEthicon U.S., LLC\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nKarl Storz GmbH \u0026amp; Co. KG\u003cbr\u003e\nStryker\u003cbr\u003e\nPENTAX Medical\u003cbr\u003e\nRichard Wolf GmbH\u003cbr\u003e\nMedtronic\u003cbr\u003e\nFUJIFILM Holdings Corp.\u003cbr\u003e\nCONMED Corp.\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 200 Pages \/ MCW16241327","offer_id":47657830056242,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-rigid-endoscopes-market-size-study-forecast-by-product-laparoscopes-arthroscopes-ureteroscopes-cystoscopes-gynecology-endoscopes-neuroendoscopes-and-others-by-end-use-hospitals-and-outpatient-facilities-and-regional-analysis-2022-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}